Caricamento...
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
The CDK7 inhibitors (CDK7i) ICEC0942 and THZ1, are promising new cancer therapeutics. Resistance to targeted drugs frequently compromises cancer treatment. We sought to identify mechanisms by which cancer cells may become resistant to CDK7i. Resistant lines were established through continuous drug s...
Salvato in:
| Pubblicato in: | Oncogene |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962093/ https://ncbi.nlm.nih.gov/pubmed/31530935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-1008-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|